"Nuevo teléfono de WhatsApp para facilitar la comunicación de nuestros pacientes con nuestro centro. 116808-1871"

During the past decade, Diagnostico Ocular conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Diagnostico Ocular" are "Geographic Atrophy" (1 trials) and "Geographic Atrophy Secondary to Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Diagnostico Ocular" in a lesser frequency.

Most popular intervention types in "Diagnostico Ocular" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "APL-2" (1 trials), "PEGCETACOPLAN (APL-2)" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diagnostico Ocular" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Diagnostico Ocular". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Diagnostico Ocular, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diagnostico Ocular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".